PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Vitamin D-binding protein and pancreatic cancer: a nested case-control study. | 25904602 | Piper MR, Freedman DM, Robien K, Kopp W, Rager H, Horst RL, Stolzenberg-Solomon RZ | Am J Clin Nutr | 2015 | PLCO |
| A prospective evaluation of C-peptide levels and colorectal adenoma incidence. | 25592235 | Murphy N, Cross AJ, Huang WY, Rajabzadeh-Heshejin V, Stanczyk F, Hayes R, Gunter MJ | Cancer Epidemiol | 2015 | PLCO |
| Genome-wide association study of survival in patients with pancreatic adenocarcinoma. | 23180869 | Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault MC, Buring JE, Canzian F… | Gut | 2014 | PLCO |
| LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. | 24316677 | Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE | Epigenetics | 2014 | PLCO |
| Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial. | 24053621 | Pinsky PF, Parnes HL, Andriole G | BJU Int. | 2014 | PLCO |
| Body mass index and mortality among blacks and whites adults in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. | 23512729 | Xiao Q, Hsing AW, Park Y, Moore SC, Matthews CE, Berrington de González A, Kitahara CM | Obesity (Silver Spring) | 2014 | PLCO |
| Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. | 25192282 | O'Grady TJ, Kitahara CM, DiRienzo AG, Boscoe FP, Gates MA | PLoS ONE | 2014 | NLST, PLCO |
| Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. | 25044253 | Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y | Urol. Oncol. | 2014 | NLST, PLCO |
| Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. | 24577803 | Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK | Cancer | 2014 | NLST, PLCO |
| Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. | 25460915 | Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD | PLoS Med. | 2014 | NLST, PLCO |
| Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis. | 25217774 | Bodelon C, Pfeiffer RM, Buys SS, Black A, Sherman ME | J. Natl. Cancer Inst. | 2014 | PLCO |
| Abnormal CA-125 levels in menopausal women without ovarian cancer. | 25127988 | Terada KY, Elia J, Kim R, Carney M, Ahn HJ | Gynecol. Oncol. | 2014 | PLCO |
| Interval lung cancers not detected on screening chest X-rays: How are they different? | 25123333 | Kvale PA, Johnson CC, Tammemägi M, Marcus PM, Zylak CJ, Spizarny DL, Hocking W, Oken M, Commins J, Ragard L, Hu P, Berg C, Prorok P | Lung Cancer | 2014 | PLCO |
| Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | 25038532 | Marcus PM, Ogden SL, Gren LH, Childs JC, Pretzel SM, Lamerato LE, Walsh K, Rozjabek HM, Mabie J, Thomas B, Riley T | Prev Med | 2014 | PLCO |
| Diabetes and pancreatic cancer survival: a prospective cohort-based study. | 24786605 | Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G | Br. J. Cancer | 2014 | PLCO |
| Modified Gleason grade of prostatic adenocarcinomas detected in the PLCO cancer screening trial. | 24594407 | Humphrey PA, Hickey TP, Riley TL, Mabie JE, Bellinger A, Strother M, Andriole GL | J. Urol. | 2014 | PLCO |
| Serum immunoglobulin e and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. | 24718282 | Olson SH, Hsu M, Wiemels JL, Bracci PM, Zhou M, Patoka J, Reisacher WR, Wang J, Kurtz RC, Silverman DT, Stolzenberg-Solomon RZ | Cancer Epidemiol. Biomarkers Prev. | 2014 | PLCO |
| Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. | 23982929 | Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, Hayes RB, Huang WY, Gunter MJ, Yeager M, Burdette L, Berndt SI, Harris CC | Int. J. Cancer | 2014 | PLCO |
| A prospective study of serum metabolites and colorectal cancer risk. | 24894841 | Cross AJ, Moore SC, Boca S, Huang WY, Xiong X, Stolzenberg-Solomon R, Sinha R, Sampson JN | Cancer | 2014 | PLCO |
| Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. | 25158036 | Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N | Gynecol. Oncol. | 2014 | PLCO |